Gene Therapy to Treat Cancer for First Time
By Press Trust of India,
Press Trust of India
| 06. 19. 2008
In the first case of its kind, doctors have treated a cancer patient by injecting him with billions of his own immune cells, a development that projects the huge power of gene therapy for the killer disease.
According to reports in the New England Journal of Medicine, US researchers treated a 52-year-old man of melanoma by cloning cells from the patients own defence system and injecting them back into his body, in a process known as "immunotherapy".
The man was free from tumours within eight weeks of undergoing the procedure. After two years he is still free from the disease which had spread to his lymph nodes and one of his lungs. "For this patient we were successful, but we would need to confirm the effectiveness of therapy in a larger study," Dr Cassian Yee, who led the team at the Fred Hutchinson Cancer Research Centre in Seattle.
The treatment, which is extremely expensive at this stage of development, showed that vast numbers of immune cells in the body can be safely and effectively used to treat skin cancer, The...
Related Articles
Artificial Intelligence (AI) has been a major focus of news recently, as it should have been, under the appropriately ridiculous name of Hugging Face, “a leading collaboration platform and community hub for machine learning, artificial intelligence, and data science.” In July, Hugging Face was hacked. The platform itself responded:
Earlier this week, we detected and responded to an intrusion into part of our production infrastructure. This one was different from anything we had handled before in one important way...
By Miryam Naddaf, Nature | 09.21.2026
A wave of epigenetic therapies is offering hope as ways to cure chronic hepatitis B — a lingering liver infection that is caused by the hepatitis B virus (HBV) and affects more than 250 million people around the world. Currently...
By Karen Weintraub, Endpoints News | 09.16.2026
To better understand certain neuropsychiatric disorders, researchers at Stanford University have bred rodents that lack a cortex and hippocampus and then replaced those missing brain cells with human ones.
The altered mice, a scientific first, provided insights that would not...
By Ryan Cross, Endpoints News | 09.02.2026
The deaths of two children who received CRISPR therapies in China have rattled scientists who work on similar genetic medicines in the US, adding new fuel to a yearslong debate about the danger of the gene therapy field’s most-used delivery...
